IP Library Granted Patent US 7,700,712
Granted Patent B2
US 7,700,712 · App. 10/570,415 · Granted Apr 20, 2010

Allylsilane containing composition

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,700,712
App. No.
10/570,415
Granted
Apr 20, 2010
Kind
B2
Abstract

The invention provides a method to reduce evolution of hydrogen gas especially during pouring gypsum models from addition cured silicones. In this respect the invention relates to an addition curable silicone composition, comprising an addition-curable siloxane compound, a siloxane crosslinker, a catalyst and an unsaturated silane compound with at least one methylene group directly attached to the unsaturation in an amount effective to reduce the amount of hydrogen gas evolved in the reaction of said composition.

Claims (134)

1. A composition comprising:

a) an addition-curable siloxane compound (A),

b) a siloxane crosslinker (B),

c) a catalyst (C), and

d) an unsaturated silane compound (D) with at least one methylene group directly attached to the unsaturation;

wherein the composition does not contain an acetylenic alcohol containing at least 6 carbon atoms;

wherein the composition sets at a temperature within the range of about 15 to 45° C.; and

wherein the unsaturated silane compound (D) has the following structure:

R 2 R 3 C═CR 1 -A-SiR 3

wherein

R can be different or equal and is H, a monovalent alkyl (C 1 -C 22 ), aryl (C 6 -C 12 ), or O—SiR 4 3 group, optionally comprising heteroatoms, with the proviso that R is not an alkoxy group or an aryloxy group,

R 1 , R 2 , R 3 can be different or equal and is H, a monovalent alkyl (C 1 -C 22 ), or aryl (C 6 -C 12 ) group, optionally comprising heteroatoms,

R 4 is a monovalent alkyl (C 1 -C 22 ) or aryl (C 6 -C 12 ) group, wherein two or three of the residues R 4 in O—SiR 4 3 can combine to a cyclic or polycyclic structure,

A is a divalent linear, branched or cyclic hydrocarbon group (C 1 -C 12 ), optionally comprising an aromatic moiety, with at least one methylene group directly attached to the unsaturation, optionally comprising O-Atoms.

2. The composition of claim 1 , further comprising an inhibitor (E).

3. The composition of claim 1 , further comprising a filler (F).

4. The composition of claim 1 , further comprising an additive (G) selected from modifiers, dyes, pigments, thixotropic agents, flow improvers, polymeric thickeners, surfactants, odorous substances, diluting agent(s) and/or flavorings.

5. The composition according to claim 1 , wherein the unsaturated silane compound (D) is present in an amount such that the hydrogen gas evolution value of said composition in 2 hours per 10.0 g of the composition is less than about 0.6 ml.

6. The composition according to claim 1 , wherein the unsaturated silane compound (D) is monofunctional.

7. The composition according to claim 1 , wherein the unsaturated silane compound (D) comprises the structural element C═CH—CH 2 or C═C(CH 3 )—CH 2 .

8. The composition according to claim 1 , wherein the molecular weight of unsaturated silane compound (D) is below or up to about 1000 gmol −1 .

9. The composition according to claim 1 , wherein the unsaturated silane compound (D) has a viscosity below or up to about 200 mPas, at 23° C.

10. The composition according to claim 1 , wherein the unsaturated silane compound (D) is selected from:

H 2 C═CH—CH 2 Si(CH 3 ) 3 ,

H 2 C═CH—(CH 2 ) 2 Si(CH 3 ) 3 ,

H 2 C═CH—(CH 2 ) 3 Si(CH 3 ) 3 ,

H 2 C═CH—(CH 2 ) 4 Si(CH 3 ) 3 ,

H 2 C═CH—(CH 2 ) 8 Si(CH 3 ) 3 ,

H 2 C═CH—CH 2 Si(i-C 3 H 7 ) 3 ,

H 2 C═CH—(CH 2 ) 2 Si(i-C 3 H 7 ) 3 ,

H 2 C═CH—(CH 2 ) 3 Si(i-C 3 H 7 ) 3 ,

H 2 C═CH—(CH 2 4 Si(i-C 3 H 7 ) 3 ,

H 2 C═CH—(CH 2 ) 8 Si(i-C 3 H 7 ) 3 ,

H 2 C═CH—CH 2 Si(CH 3 ) 2 (t-C 4 H 9 ),

H 2 C═CH—(CH 2 ) 2 Si(CH 3 ) 2 (t-C 4 H 9 ),

H 2 C═CH—(CH 2 ) 3 Si(CH 3 ) 2 (t-C 4 H 9 ),

H 2 C═CH—(CH 2 ) 4 Si(CH 3 ) 2 (t-C 4 H 9 ),

H 2 C═CH—(CH 2 ) 8 Si(CH 3 ) 2 (t-C 4 H 9 ),

H 2 C═CH—CH 2 Si(C 2 H 5 ) 3 ,

H 2 C═CH—(CH 2 ) 2 Si(C 2 H 5 ) 3 ,

H 2 C═CH—(CH 2 ) 3 Si(C 2 H 5 ) 3 ,

H 2 C═CH—(CH 2 ) 4 Si(C 2 H 5 ) 3 ,

H 2 C═CH—(CH 2 ) 8 Si(C 2 H 5 ) 3 ,

H 2 C═CH—CH 2 Si(CH 3 ) 2 (n-C 18 H 37 ),

H 2 C═CH—(CH 2 ) 2 Si(CH 3 ) 2 (n-C 18 H 37 ),

H 2 C═CH—(CH 2 ) 3 Si(CH 3 ) 2 (n-C 18 H 37 ),

H 2 C═CH—(CH 2 ) 4 Si(CH 3 ) 2 (n-C 18 H 37 ),

H 2 C═CH—(CH 2 ) 8 Si(CH 3 ) 2 (n-C 18 H 37 ),

H 2 C═CH—CH 2 Si(CH 3 ) 2 (C 6 H 5 ),

H 2 C═CH—(CH 2 ) 2 Si(CH 3 ) 2 (C 6 H 5 ),

H 2 C═CH—(CH 2 ) 3 Si(CH 3 ) 2 (C 6 H 5 ),

H 2 C═CH—(CH 2 ) 4 Si(CH 3 ) 2 (C 6 H 5 ),

H 2 C═CH—(CH 2 ) 8 Si(CH 3 ) 2 (C 6 H 5 ),

H 2 C═CH—CH 2 —O—Si(CH 3 ) 3 ,

H 2 C═CH—CH 2 —O—Si(C 2 H 5 ) 3 ,

H 2 C═CH—CH 2 —O—Si(i-C 3 H 7 ) 3 ,

H 2 C═CH—CH 2 —O—Si(CH 3 ) 2 (t-C 4 H 9 ),

H 2 C═CH—CH 2 —O—Si(CH 3 ) 2 (n-C 18 H 37 ),

H 2 C═CH—CH 2 —O—Si(CH 3 ) 2 (C 6 H 5 ),

H 2 C═CH—CH 2 Si(CH 3 ) 2 —O—Si(CH 3 ) 3 ,

H 2 C═CH—(CH 2 ) 2 Si(CH 3 ) 2 —O—Si(CH 3 ) 3 ,

H 2 C═CH—(CH 2 ) 3 Si(CH 3 ) 2 —O—Si(CH 3 ) 3 ,

H 2 C═CH—(CH 2 ) 4 Si(CH 3 ) 2 —O—Si(CH 3 ) 3 ,

H 2 C═CH—(CH 2 ) 8 Si(CH 3 ) 2 —O—Si(CH 3 ) 3 ,

H 2 C═CH—CH 2 Si(CH 3 )(—O—Si(CH 3 ) 3 ) 2 ,

H 2 C═CH—(CH 2 ) 2 Si(CH 3 )(—O—Si(CH 3 ) 3 ) 2 ,

H 2 C═CH—(CH 2 ) 3 Si(CH 3 )(—O—Si(CH 3 ) 3 ) 2 ,

H 2 C═CH—(CH 2 ) 4 Si(CH 3 )(—O—Si(CH 3 ) 3 ) 2 ,

H 2 C═CH—(CH 2 ) 8 Si(CH 3 )(—O—Si(CH 3 ) 3 ) 2 ,

H 2 C═CH—CH 2 Si(—O—Si(CH 3 ) 3 ) 3 ,

H 2 C═CH—(CH 2 ) 2 Si(—O—Si(CH 3 ) 3 ) 3 ,

H 2 C═CH—(CH 2 ) 3 Si(—O—Si(CH 3 ) 3 ) 3 ,

H 2 C═CH—(CH 2 ) 4 Si(—O—Si(CH 3 ) 3 ) 3 ,

H 2 C═CH—(CH 2 ) 8 Si(—O—Si(CH 3 ) 3 ) 3 ,

H 2 C═CH—CH 2 Si(C 6 H 5 ) 3 ,

H 2 C=CH—(CH 2 ) 2 Si(C 6 H 5 ) 3 ,

H 2 C═CH—(CH 2 ) 3 Si(C 6 H 5 ) 3 ,

H 2 C═CH—(CH 2 ) 4 Si(C 6 H 5 ) 3 ,

H 2 C═CH—(CH 2 ) 8 Si(C 6 H 5 ) 3 ,

H 2 C═C(CH 3 )—CH 2 Si(CH 3 ) 3 ,

(2-Cyclopentenyl)Si(CH 3 ) 3 ,

(Cyclopentadienyl)Si(CH 3 ) 3 ,

H 2 C═CH—CH 2 Si(p-C 6 H 4 OCH 3 ),

1-Allyl-,3,5,7,9,11,13,15-heptacyclopentyl-pentacyclo[9.5.1 3,9 1 5,15 .1 7,13 ]octasiloxan,

1-Allyl-3,5,7,9,11,13,15-heptaisopropyl-pentacyclo[9.5.1 3,9 1 5,15 .1 7,13 ]octasiloxan,

H 2 C═CH—CH 2 Si(CH 3 ) 2 H,

H 2 C═CH—(CH 2 ) 2 Si(CH 3 ) 2 H,

H 2 C═CH—(CH 2 ) 3 Si(CH 3 ) 2 H,

H 2 C═CH—(CH 2 ) 4 Si(CH 3 ) 2 H, and

H 2 C═CH—(CH 2 ) 8 Si(CH 3 ) 2 H.

11. The composition according to claim 1 , wherein the molecular weight of component (A) before curing is in the range of about 600 to about 200000 g/mol.

12. The composition according to claim 1 having a shore hardness A of the cured composition measured according to DIN 53505 60 min after mixing the components in the range of about 30 to about 95.

13. The composition according to claim 1 having a tensile strength of the cured composition measured according to DIN 50125 120 min after mixing the components in the range of about 0.5 to about 5 MPa.

14. The composition according to claim 1 , wherein said composition is selected from the group consisting of impression materials and molding materials.

15. The composition of claim 1 , wherein composition comprises an amount of the unsaturated silane compound (D) from 0.001% to 10% by weight with respect to the cured composition.

16. A kit of parts, comprising a base part (I) and a catalyst part (II), wherein the base part (I) comprises an addition-curable siloxane compound and a siloxane crosslinker, and the catalyst part (II) comprises a catalyst, wherein the kit further comprises an unsaturated silane compound with at least one methylene group directly attached to the unsaturation, said silane compound being present in either the base part (I) or the catalyst part (II) or in the base part (I) and the catalyst part (II), wherein a composition formed by combining the base part (I) and the catalyst part (II) sets at a temperature within the range of about 15 to 45° C., and wherein the unsaturated silane compound has the following structure:

R 2 R 3 C═CR 1 -A-SiR 3

wherein

R can be different or equal and is H, a monovalent alkyl (C 1 -C 22 ), aryl (C 6 -C 12 ), or O—SiR 4 3 group, optionally comprising heteroatoms, with the proviso that R is not an alkoxy group or an aryloxy group,

R 1 , R 2 , R 3 can be different or equal and is H, a monovalent alkyl (C 1 -C 22 ), or aryl (C 6 -C 12 ) group, optionally comprising heteroatoms,

R 4 is a monovalent alkyl (C 1 -C 22 ) or aryl (C 6 -C 12 ) group, wherein two or three of the residues R 4 in O—SiR 4 3 can combine to a cyclic or polycyclic structure,

A is a divalent linear, branched or cyclic hydrocarbon group (C 1 -C 12 ), optionally comprising an aromatic moiety, with at least one methylene group directly attached to the unsaturation, optionally comprising O-Atoms.

17. The kit of claim 16 further comprising an inhibitor, a filler and an additive selected from modifiers, dyes, pigments, thixotropic agents, flow improvers, polymeric thickeners, surfactants, odorous substances, diluting agent(s) and/or flavorings, wherein the composition does not contain an acetylenic alcohol containing at least 6 carbon atoms, each of which may be present either in the base part (I) or the catalyst part (II) or in the base part (I) and the catalyst part (II).

18. A method of reducing the amount of hydrogen gas evolved in the reaction of an addition-curable silicone composition, said method comprising adding to the composition an unsaturated silane compound, wherein the composition sets at a temperature of about 15 to 45° C., and wherein the unsaturated silane compound has the following structure:

R 2 R 3 C═CR 1 -A-SiR 3

wherein

R can be different or equal and is H, a monovalent alkyl (C 1 -C 22 ), aryl (C 6 -C 12 ), or O—SiR 4 3 group, optionally comprising heteroatoms, with the proviso that R is not an alkoxy group or an aryloxy group,

R 1 , R 2 , R 3 can be different or equal and is H, a monovalent alkyl (C 1 -C 22 ), or aryl (C 6 -C 12 ) group, optionally comprising heteroatoms,

R 4 is a monovalent alkyl (C 1 -C 22 ) or aryl (C 6 -C 12 ) group, wherein two or three of the residues R 4 in O—SiR 4 3 can combine to a cyclic or polycyclic structure,

A is a divalent linear, branched or cyclic hydrocarbon group (C 1 -C 12 ), optionally comprising an aromatic moiety, with at least one methylene group directly attached to the unsaturation, optionally comprising O-Atoms.

19. The method according to claim 18 , wherein the unsaturated silane compound is present in an amount such that the hydrogen gas evolution value of said composition in 2 hours per 10.0 g of the composition is less than about 0.6 ml.

20. The method according to claim 18 , wherein the amount of the unsaturated silane compound is up to about 10% by weight with respect to the cured composition.

21. The method according to claim 18 , wherein the unsaturated silane compound is monofunctional.

22. The method according to claim 18 , wherein the unsaturated silane compound comprises the structural element C═CH—CH 2 or C═C(CH 3 )—CH 2 .

23. The method according to claim 18 , wherein the molecular weight of unsaturated silane compound is below or up to about 1000 gmol −1 .

24. A method of producing a curable composition, said method comprising the steps of:

i) providing an addition-curable siloxane compound, a siloxane crosslinker, a catalyst, and an unsaturated silane compound with at least one methylene group directly attached to the unsaturation, and

ii) mixing the components,

wherein the composition sets at a temperature of about 15 to 45° C., and wherein the unsaturated silane compound has the following structure:

R 2 R 3 C═CR 1 -A-SiR 3

wherein

R can be different or equal and is H, a monovalent alkyl (C 1 -C 22 ), aryl (C 6 -C 12 ), or O—SiR 4 3 group, optionally comprising heteroatoms, with the proviso that R is not an alkoxy group or an aryloxy group,

R 1 , R 2 , R 3 can be different or equal and is H, a monovalent alkyl (C 1 -C 22 ), or aryl (C 6 -C 12 ) group, optionally comprising heteroatoms, R 4 is a monovalent alkyl (C 1 -C 22 ) or aryl (C 6 -C 12 ) group, wherein two or three of the residues R 4 in O—SiR 4 3 can combine to a cyclic or polycyclic structure,

A is a divalent linear, branched or cyclic hydrocarbon group (C 1 -C 12 ), optionally comprising an aromatic moiety, with at least one methylene group directly attached to the unsaturation, optionally comprising O-Atoms.

25. A method of preparing a positive model, comprising the steps of:

a) providing a composition comprising:

i) an addition-curable siloxane compound (A),

ii) a siloxane crosslinker (B),

iii) a catalyst (C), and

iv) an unsaturated silane compound (D) with at least one methylene group directly attached to the unsaturation in an amount effective to reduce the amount of hydrogen gas evolved in the reaction of said composition;

wherein the composition does not contain an acetylenic alcohol containing at least 6 carbon atoms;

b) contacting the composition with a surface to obtain a negative model,

c) curing the composition, and

d) pouring the negative model after removal of the cured composition from the surface with a pouring composition to obtain a positive model.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2024
From: 3M DEUTSCHLAND GMBH
To: 3M HEALTHCARE GERMANY GMBH
Reel/Frame 066501/0818 →
CORRECTIVE BY NULLIFICATION TO CORRECT INCORRECTLY RECORDED APPLICATION/PATENT NUMBERS (SEE ATTACHMENT) AT REEL/FRAME 055223/0805. ASSIGNOR HEREBY CONFIRMS THE CHANGE OF ADDRESS. Recorded Sep 16, 2021
From: MAMMOTH BIOSCIENCES, INC.
To: MAMMOTH BIOSCIENCES, INC.
Reel/Frame 057525/0141 →
MERGER Recorded Feb 27, 2012
From: 3M ESPE AG
To: 3M DEUTSCHLAND GMBH
Reel/Frame 027762/0754 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2006
From: ZECH, JOACHIM W.; HOFFMANN, HENNING; BISSINGER, PETER; STEIGER, WOLF
To: 3M ESPE AG
Reel/Frame 017647/0005 →